KEDRICK ST FLOYD: Open Payments
NPI 1821693011 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $170 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Lundbeck LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: REXULTI, VRAYLAR, Auvelity, SPRAVATO, AUSTEDO XR, CAPLYTA, TRINTELLIX, UZEDY.
Industry payments across TX — which companies pay providers there.
